Business Context and Reporting Period
This Form 8-K is filed by Intelligent Bio Solutions Inc. (INBS), a Delaware corporation listed on The Nasdaq Stock Market LLC. The report date is February 27, 2023, with the document signed on March 2, 2023. The filing addresses a specific regulatory event regarding the company's listing status on Nasdaq.
Key Financial Metrics
This filing is an "Other Events" report (Item 8.01) and does not contain financial statements, revenue figures, profit data, cash flow, margins, debt levels, or liquidity metrics. The filing text does not provide a clear value for any financial performance indicators.
Material Changes
The primary material change reported is the resolution of a listing deficiency:
- Previous Status: On March 17, 2022, the company received notice from Nasdaq that it failed to meet the $1.00 minimum bid price requirement (Listing Rule 5450(a)(1)) for 30 consecutive business days.
- Current Status: On February 27, 2023, Nasdaq notified the company that it regained compliance. The common stock's closing bid price was at or above $1.00 for 10 consecutive business days between February 10, 2023, and February 24, 2023.
- Outcome: Nasdaq considers the matter closed, and the company is now in full compliance with the Minimum Bid Price Requirement.
Guidance, Outlook, and Risks
The filing does not provide forward-looking guidance, management commentary on future operations, or specific risk factors beyond the context of the listing compliance. The company issued a press release on March 1, 2023, confirming the regained compliance, which is attached as Exhibit 99.1. No unusual items or contingencies are disclosed in this specific report.
Investor Verification Checklist
- Verify the current trading price of INBS to ensure it remains above the $1.00 threshold to maintain Nasdaq compliance.
- Review the attached Press Release (Exhibit 99.1) for any additional context regarding the stock price performance during the compliance period.
- Check subsequent filings for any new notices from Nasdaq regarding other listing standards (e.g., market value of listed securities or shareholder equity).